Neoadjuvant chemotherapy of esophageal cancer

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter M. Ribeiro
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors M. Ribeiro, S. Povoa, N. Tavares, C. Marques, C. Fernandes, D. Almeida, I. Augusto
  • /

Abstract

Despite recent scientific advances in the detection and treatment of esophageal cancer, overall survival (OS) and disease-free survival (DFS) of these patients remain lower than most solid tumors. Neoadjuvant chemoradiotherapy increases rates of complete pathological response (pCR), R0 resections and local tumor control.